MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.58

+1.4%

Nov 5 12:44 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1905)	12/12/2007 2:34:17 PM
From: Icebrg	of 2240

Medarex downgraded to "peer perform" Tuesday, December 11, 2007 10:48:38 AM ET Bear Stearns NEW YORK, December 11 (newratings.com) - Analyst Akhtar Samad of Bear Stearns downgrades Medarex Inc (MEDX.NAS) from "outperform" to "peer perform." In a research note published this morning, the analyst mentions that Ipilimumab has failed to meet its primary endpoint for the Phase III second-line melanoma monotherapy open label trial with an SPA. The failure has raised the risk of non-approval of Ipilimumab by the FDA and for the remainder of the Phase III trials for Ipilimumab, the data for which is not scheduled for release until late-2008, the analyst adds.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next